布地奈德联合孟鲁斯特治疗小儿哮喘临床疗效及其对患儿肺功能影响的研究

Discussion on Clinical Value of Budesonide Combine with Montelukast to Improve Pulmonary Function for Pediatric Asthma

目的：研究布地奈德联合孟鲁斯特治疗小儿哮喘的临床疗效及其对患儿肺功能的影响。方法：选择某院2014年1月-2015年1月收治的哮喘患儿80例,按照治疗方式的不同将全部患儿分成两组;40例对照组患儿采用布地奈德治疗,40例实验组患儿采用布地奈德联合孟鲁斯特治疗。结果：在临床有效率以及治疗6个月后的FEV1%方面,实验组患儿均显著优于对照组患儿（P〈0.05）。结论：布地奈德联合孟鲁斯特治疗小儿哮喘的效果显著,能对患儿的肺功能进行有效改善,值得临床推广。

Objective To discuss the clinical value of the Budesonide combine with Montelukast to improve Pulmonary function for the Pediatric asthma.Methods： According to the different methods of treatment ,divide 80 cases of sick children into the control group and the experimental group,40 cases of sick children in the control group using Budesonide for treatment , 40 cases of sick children in the experimental group using Budesonide combine with Montelukast, and then compare the clinical value of two groups patients. Results： The clinical total effective treatment in the experimental group is obviously higher than the control group （P 〈0.05） ; after one year treatment , the FEV 1 % of the experimental group sick children is obviously higher than that in the control group （P 〈0.05）. Conclusion： In the clinical treatment for thePediatric asthma , Budesonide combineD with Montelukast got curative clinical effects,and it＇s obviously improved the Pulmonary function of the sick children, which has highly application value.